MedPath

Evaluation of Tetrix Cream in the Healing of Injured Skin in Subjects With Contact Dermatitis

Not Applicable
Completed
Conditions
Healthy
Interventions
Device: Tetrix
Registration Number
NCT00643214
Lead Sponsor
Coria Laboratories, Ltd.
Brief Summary

To determine if Tetrix Cream,, when applied to the skin lesions on patients with contact dermatitis, slows or interferes with the healing of the lesions.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
12
Inclusion Criteria
  • Normal subjects with sensitivity to nickel.
Exclusion Criteria
  • Under 18 years of age.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
1TetrixTwice daily topical application
2TetrixTwice daily topical application
Primary Outcome Measures
NameTimeMethod
Clearing of signs and symptoms of contact dermatitis10 days after induction of lesion and start of treatment
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Dermatology Specialists, LLC

🇺🇸

Louisville, Kentucky, United States

© Copyright 2025. All Rights Reserved by MedPath